| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 12/11/2003 | WO2003102584A2 Semaphorin-like proteins and methods of using same |
| 12/11/2003 | WO2003102582A1 Method for detecting biochemical reagin biochip |
| 12/11/2003 | WO2003102581A2 Assay for glycosylated proteins |
| 12/11/2003 | WO2003102578A2 High throughput cellular response assay using microarrays |
| 12/11/2003 | WO2003102544A2 Assays for measuring matrix metalloproteinase activities |
| 12/11/2003 | WO2003102245A1 Antisense modulation of beta-site app-cleaving enzyme 2 expression |
| 12/11/2003 | WO2003102243A1 Methods for improving rna transcription reactions |
| 12/11/2003 | WO2003102241A1 Integrated micro array system and methods therefor |
| 12/11/2003 | WO2003102240A1 A method for identification of obese il-6 responsive patients |
| 12/11/2003 | WO2003102239A2 Met/fret based method of target nucleic acid detection whereby the donor/acceptor moieties are on complementary strands |
| 12/11/2003 | WO2003102238A2 Direct pcr quantification |
| 12/11/2003 | WO2003102237A1 Treatment with cytokines |
| 12/11/2003 | WO2003102236A1 Method for determing ethnic origin by means of str profile |
| 12/11/2003 | WO2003102235A2 Specific genetic markets for cytogenetically defined acute myeloid leukaemia |
| 12/11/2003 | WO2003102234A1 Method for high-throughput integrated chemical and biochemical reactions |
| 12/11/2003 | WO2003102233A1 Novel high density arrays and methods for analyte analysis |
| 12/11/2003 | WO2003102232A2 Amplification of ribonucleic acids |
| 12/11/2003 | WO2003102231A1 Method for parallelly sequencing a nucleic acid mixture by using a continuous flow system |
| 12/11/2003 | WO2003102230A1 Pthrp-based prediction and diagnosis of bone disease |
| 12/11/2003 | WO2003102229A1 HEMATOLOGIC AND RENAL OR CARDIOVASCULAR PHENOTYPES IN RELATION TO THE POLYMORPHISM IN THE β-ADDUCIN GENE |
| 12/11/2003 | WO2003102228A1 A nucleic acid anchoring system comprising covalent linkage of an oligonucleotide to a solid support |
| 12/11/2003 | WO2003102227A1 Gene expression and multiple sclerosis |
| 12/11/2003 | WO2003102226A1 Improved dna amplification apparatus and method |
| 12/11/2003 | WO2003102224A1 Method of counting microorganisms or cells |
| 12/11/2003 | WO2003102223A1 Method of detecting arcenic ions with indicator bacteria |
| 12/11/2003 | WO2003102222A2 Continuous-flow enzyme assay with mass spectrometry detection |
| 12/11/2003 | WO2003102221A1 Screening method for regulatory enzymes employing tribrid (tri-hybrid) system |
| 12/11/2003 | WO2003102216A2 Multiplexed systems for nucleic acid sequencing |
| 12/11/2003 | WO2003102215A2 Methods of identifying and isolating stem cells and cancer stem cells |
| 12/11/2003 | WO2003102214A2 Method for efficient rna interference in mammalian cells |
| 12/11/2003 | WO2003102213A2 Error-prone dna polymerase i mutants and methods for targeted random mutagenesis in continuous culture using error-prone dna polymerase i mutants |
| 12/11/2003 | WO2003102212A2 In vitro evaluation of nucleic acid ligands |
| 12/11/2003 | WO2003102211A2 Method of detecting dna variation in sequence data |
| 12/11/2003 | WO2003102206A2 Sgk and nedd used as diagnostic and therapeutic targets |
| 12/11/2003 | WO2003102191A1 Immunogenic sequences |
| 12/11/2003 | WO2003102189A1 Allergen from mugwort pollen |
| 12/11/2003 | WO2003102188A1 Mutated androgen receptor, cancer cells expressing the same, method of constructing the same and use thereof |
| 12/11/2003 | WO2003102184A1 Methods, compositions and kits for cell separation |
| 12/11/2003 | WO2003102182A1 Inflammatory skin disease-related slurp-2 gene and utilization thereof |
| 12/11/2003 | WO2003102181A1 Method of detecting gene polymorphism |
| 12/11/2003 | WO2003102179A1 Novel method of assyaing nucleic acid using labeled nucleotide |
| 12/11/2003 | WO2003102178A1 Method of typing gene polymorphisms |
| 12/11/2003 | WO2003102177A1 METHOD OF SCREENING COMPOUND AFFECTING AMYLOID β PRODUCTION |
| 12/11/2003 | WO2003102176A1 Transgenic clawed frog embryos and use thereof as detectors of endocrine disrupters in the environment |
| 12/11/2003 | WO2003102166A2 Novel flavivirus antigens |
| 12/11/2003 | WO2003102163A2 Methods of diagnosing and treating diabetes and insulin resistance |
| 12/11/2003 | WO2003102159A2 Novel proteins and nucleic acids encoding same |
| 12/11/2003 | WO2003102154A2 Improved receptor detection |
| 12/11/2003 | WO2003102146A2 Aptamer constructs |
| 12/11/2003 | WO2003102143A2 HUMAN COACTIVATOR-ASSOCIATED ARGININE METHYLTRANSFERASE 1 (hCARM1) |
| 12/11/2003 | WO2003102142A2 Arrays identifying genomic and proteomic biomarkers for cystic fibrosis |
| 12/11/2003 | WO2003102141A2 Identification of a gene causing the most common form of bardet-biedl syndrome and uses thereof |
| 12/11/2003 | WO2003102140A2 Cftr modifier genes and expressed polypeptides useful in treating cystic fibrosis |
| 12/11/2003 | WO2003102137A2 Compositions and methods relating to lung specific genes and proteins |
| 12/11/2003 | WO2003102135A2 Control sequences of the human corin gene |
| 12/11/2003 | WO2003102130A2 A human cell assay to determine effect of sample compounds on col2 enhancer expression |
| 12/11/2003 | WO2003102127A2 Human 5-ht7 receptor promoter sequence |
| 12/11/2003 | WO2003102124A2 Method and apparatus for measuring nitric oxide production and oxygen consumption in cultures of adherent cells |
| 12/11/2003 | WO2003102031A1 Proteins and methods useful for assessing risk of cardiovascular disease |
| 12/11/2003 | WO2003102028A1 Rb1 gene induced protein (rb1cc1) and gene |
| 12/11/2003 | WO2003102025A1 Protein inducing cell death of helicobacter pylori |
| 12/11/2003 | WO2003102018A2 Methods for quantitative proteome analysis of glycoproteins |
| 12/11/2003 | WO2003102011A1 Method for determining oligonucleotide concentration |
| 12/11/2003 | WO2003101497A1 Knockout mice and their use |
| 12/11/2003 | WO2003101487A1 Use of inhibitors of phospholipase a2 for the treatment, prevention or diagnosis of neural inflammatory or demyelinating disease |
| 12/11/2003 | WO2003101401A2 Use of nrg4, or inhibitors thereof, in the treatment of colon and pancreatic cancer |
| 12/11/2003 | WO2003101400A2 Cancer-linked gene as target for chemotherapy |
| 12/11/2003 | WO2003101394A2 Defensins: use as antiviral agents |
| 12/11/2003 | WO2003101386A2 Kinase suppressor of ras inactivation for therapy of ras mediated tumorigenesis |
| 12/11/2003 | WO2003101377A2 Association of snps in the dgcr2 locus and neighboring loci with schizophrenia |
| 12/11/2003 | WO2003101278A2 Device and method of use for detection and characterization of pathogens and biological materials |
| 12/11/2003 | WO2003101177A2 Diagnosing predisposition to fat deposition and therapeutic methods for reducing fat deposition and treatment of associated conditions |
| 12/11/2003 | WO2003091404A3 Formation and use of site specific nucleic acid coupled binding polypeptides |
| 12/11/2003 | WO2003080823A3 Bacteriophages useful for therapy and prophylaxis of bacterial infections |
| 12/11/2003 | WO2003076082A3 Surface-energy gradient on a fluid-impervious surface and method of its creation using a mixed monolayer film |
| 12/11/2003 | WO2003075007A3 Methods for absolute cell counting |
| 12/11/2003 | WO2003073068A3 Population based assessments and means to rank the relative immunogenicity of proteins |
| 12/11/2003 | WO2003070882A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and used thereof |
| 12/11/2003 | WO2003070265A3 Hedgehog-related prophylaxis, therapy and diagnosis of gi tract carcinogenesis |
| 12/11/2003 | WO2003066885A3 Method for screening for compounds having hdac inhibitory activity |
| 12/11/2003 | WO2003066079A3 Novel epitopes for celiac disease and autoimmune diseases, methods for detecting those and novel non-antigenic food compounds |
| 12/11/2003 | WO2003064696A3 Methods for reducing contamination by genetically modified plant products |
| 12/11/2003 | WO2003064624A3 Molecular hepatotoxicology modeling |
| 12/11/2003 | WO2003064463A3 Pluripotency determining factors and uses thereof |
| 12/11/2003 | WO2003060465A3 Compositions, kits, and methods for identification, assessment, prevention, and therapy of rheumatoid arthritis |
| 12/11/2003 | WO2003060163A3 Discrimination and detection of target nucleotide sequences using mass spectrometry |
| 12/11/2003 | WO2003060074A3 Novel metastasis suppressor gene on human chromosome 8 |
| 12/11/2003 | WO2003059877A3 Novel affinity labels |
| 12/11/2003 | WO2003056296A3 Improved methods for determining binding affinities |
| 12/11/2003 | WO2003054792A3 System and methods for measuring at least one metabolic rate of a plurality of cells |
| 12/11/2003 | WO2003054232A3 Methods for removal of double-stranded oligonucleotides containing sequence errors using mismatch recognition proteins |
| 12/11/2003 | WO2003054212A3 A method and compositions for conferring viral immunity and reversing viral pathogenesis via strategic infection with a theravirus thereby providing genomic integration of genetically engineered, replication incompetent, integrating viral dna |
| 12/11/2003 | WO2003053857A9 Forming and modifying dielctrically-engineered microparticles |
| 12/11/2003 | WO2003052116A3 Methods for detection of a target nucleic acid using multi-subunit probes |
| 12/11/2003 | WO2003052076A3 Identification of essential genes of cryptococcus neoformans and methods of use |
| 12/11/2003 | WO2003051180A3 METHODS AND COMPOSITIONS FOR TREATING HEMATOLOGICAL DISORDERS USING 252, 304, 19870, 14717, 9941, 19310 and 17832 |
| 12/11/2003 | WO2003050296A3 Method for determining the activity of ornithine decarboxylase and for identifying effectors of ornithine decarboxylase activity |
| 12/11/2003 | WO2003048304A3 ALLOIOCOCCUS OTITIDIS OPEN READING FRAMES (ORFs) ENCODING POLYPEPTIDE ANTIGENS, IMMUNOGENIC COMPOSITIONS AND USES THEREOF |
| 12/11/2003 | WO2003044039A3 Atrial natriuretic peptide clearance receptor variant associated with bone disorders |
| 12/11/2003 | WO2003040400A3 Methods for detecting and quantifying binding and inhibition of binding of species to nucleic acids |